DIGITAL HEALTH LEARNING NETWORK

The Digital Health Learning Network (DHLN) is a group of innovation leaders from industry, who come together specifically to understand what a patient-centric future means for Life Sciences and Healthcare. The DHLN is hosted and supported by Cambridge Digital Innovation, organising the Network’s meetings, facilitating networking, and developing knowledge through white papers, podcasts, and webinars.

As the industry moves towards a patient-centric future the key questions of how this will manifest, what will enable it, the regulatory effect, and most importantly how this will help people lead healthy lives, must be addressed. Digital innovation is accelerating the pace of these changes, so it has never been more important, or challenging, for leaders in Life Science and Healthcare to understand the nature of impending disruptive innovations.

Objectives

Help companies operating in Life Science & Healthcare identify disruptive innovations.

Build a community of like-minded people in digital transformation.

Encourage innovators to develop offerings with customers and collaborators.

Develop a medium- to long-term perspective on how Life Science & Healthcare could develop.

Areas of interest

Internet of things

Devices capable of interconnecting to collect and exchange data.

Cognitive computing

Self-learning systems that use data mining, pattern recognition and natural language processing.

Social Engagement

Degree of participation in a community or society.

Members

Meetings

Please reload

The Digital Health Learning Network (DHLN) is a group of innovation leaders from industry, who come together specifically to understand what a patient-centric future means for Life Sciences and Healthcare. The DHLN is hosted and supported by Cambridge Digital Innovation, organising the Network’s meetings, facilitating networking, and developing knowledge through white papers, podcasts, and webinars.

As the industry moves towards a patient-centric future the key questions of how this will manifest, what will enable it, the regulatory effect, and most importantly how this will help people lead healthy lives, must be addressed. Digital innovation is accelerating the pace of these changes, so it has never been more important, or challenging, for leaders in Life Science and Healthcare to understand the nature of impending disruptive innovations.

Objectives

Help companies operating in Life Science & Healthcare identify disruptive innovations.

Build a community of like-minded people in digital transformation.

Encourage innovators to develop offerings with customers and collaborators.

Develop a medium- to long-term perspective on how Life Science & Healthcare could develop.

Meetings

Next meeting

TBA

Previous meetings

18 Jun 2018

Health data security, the future of tele-health & innovation scaling

15 Mar 2018

Developing innovation in the health ecosystem

7 Dec 2017

Nurturing innovation

7 Sep 2017

New approaches to patient engagement

30 Mar 2017

Impact of artificial intelligence

Areas of interest

Internet of things

Devices capable of interconnecting to collect and exchange data.

Cognitive computing

Self-learning systems that use data mining, pattern recognition and natural language processing.

Social Engagement

Degree of participation in a community or society.

Outputs

The outputs of DHLN meetings are available online.

Selected DHLN Briefs include:

Microservices: Designing for innovation

Design thinking for nurturing innovation

Click here to access further outputs from all the DHLN meetings.

Members

Junaid Bajwa

Executive Director of Healthcare Services, MSD

Prof Michael Barrett

Cambridge Judge Business School

Christina Donatti

IMI Lead, Real World Evidence, EMEA Strategic Organisation, Janssen Cilag

Dr Amer Fasihi

Founder, Caros Connect

Please reload

Shahid Hanif

Head of Health Data & Outcomes, Association of the British Pharmaceutical Industry

Sammeli Liikkanen

Chief Digital Officer, Orion Corporation

Guido Radack

Director, Global Clinical Information Technology & Solutions, Bayer HealthCare

Pratik Thakkar

Medical Advisor (Immuno-oncology), Bristol-Myers Squibb

Please reload

© 2017

Cambridge Digital Innovation

Hughes Hall, University of Cambridge

Cambridge Judge Business School

  • Facebook - Grey Circle
  • Twitter - Grey Circle
  • LinkedIn - Grey Circle